The curious case of Merkel cell carcinoma: epigenetic youth and lack of pluripotency.


Journal

Epigenetics
ISSN: 1559-2308
Titre abrégé: Epigenetics
Pays: United States
ID NLM: 101265293

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 2 6 2020
medline: 22 6 2021
entrez: 2 6 2020
Statut: ppublish

Résumé

Merkel cell carcinoma (MCC) is a very rare, but highly aggressive skin cancer which occurs mainly in elderly patients. MCC cells show an expression pattern of three cell lineages: epithelial, neuroendocrine, and B-cell progenitor. This trilinear expression pattern suggests stemness activity in MCC. The etiopathogenesis of MCC is either linked to the Merkel cell polyomavirus (MCPyV) or in a smaller proportion (20%) to high levels of UV-induced somatic mutations. Both viral presence and accumulation of mutations have been shown to be associated with accelerated DNA methylation Age (DNAmAge) compared to chronological age. The MCC DNAmAge was significantly lower compared to the chronological age, which was irrespective of the viral presence or mutational burden. Although these features indicate some aspects of stemness in MCC cells, gene-expression-based pluripotency testing did not provide evidence for pluripotency of MCC cells.

Identifiants

pubmed: 32475296
doi: 10.1080/15592294.2020.1773096
pmc: PMC7678933
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1319-1324

Références

Eur J Cancer. 2017 Jan;71:53-69
pubmed: 27984768
Nat Methods. 2011 Apr;8(4):315-7
pubmed: 21378979
Genome Biol. 2015 May 13;16:96
pubmed: 25968125
Clin Epigenetics. 2020 Feb 10;12(1):23
pubmed: 32041662
Int J Cancer. 2002 Sep 10;101(2):137-45
pubmed: 12209990
Lab Invest. 1987 Mar;56(3):302-12
pubmed: 3546933
Front Oncol. 2019 Jun 10;9:451
pubmed: 31245285
Genome Biol. 2013;14(10):R115
pubmed: 24138928
Crit Rev Oncol Hematol. 2017 Aug;116:99-105
pubmed: 28693804
J Virol. 2010 Jul;84(14):7064-72
pubmed: 20444890
Haematologica. 2017 Aug;102(8):e321-e323
pubmed: 28550187
Curr Environ Health Rep. 2018 Sep;5(3):317-327
pubmed: 30047075
Nat Rev Clin Oncol. 2018 Dec;15(12):763-776
pubmed: 30287935
Int J Cancer. 1995 Jan 3;60(1):100-7
pubmed: 7814141

Auteurs

Emil Chteinberg (E)

Department of Pathology, GROW-School for Oncology & Developmental Biology, Maastricht University, Medical Centre+ , Maastricht, The Netherlands.
Institute for Biomedical Engineering, Department of Cell Biology, RWTH Aachen, University Hospital , Aachen, Germany.
Helmholtz Institute for Biomedical Engineering, RWTH Aachen University , Aachen, Germany.

Julia Vogt (J)

Institute of Human Genetics, Ulm University and Ulm University Medical Center , Ulm, Germany.

Julia Kolarova (J)

Institute of Human Genetics, Ulm University and Ulm University Medical Center , Ulm, Germany.

Felix Bormann (F)

Bioinformatics.Expert UG , Berlin, Germany.

Joost van den Oord (J)

Department of Pathology and Laboratory Translational Cell and Tissue Research, University of Leuven , KU, Leuven, Belgium.

Ernst Jan Speel (EJ)

Department of Pathology, GROW-School for Oncology & Developmental Biology, Maastricht University, Medical Centre+ , Maastricht, The Netherlands.

Véronique Winnepenninckx (V)

Department of Pathology, GROW-School for Oncology & Developmental Biology, Maastricht University, Medical Centre+ , Maastricht, The Netherlands.

Anna Kordelia Kurz (AK)

Department of Internal Medicine IV, University Hospital Aachen , Aachen, Germany.

Martin Zenke (M)

Institute for Biomedical Engineering, Department of Cell Biology, RWTH Aachen, University Hospital , Aachen, Germany.
Helmholtz Institute for Biomedical Engineering, RWTH Aachen University , Aachen, Germany.

Reiner Siebert (R)

Institute of Human Genetics, Ulm University and Ulm University Medical Center , Ulm, Germany.

Axel Zur Hausen (AZ)

Department of Pathology, GROW-School for Oncology & Developmental Biology, Maastricht University, Medical Centre+ , Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH